Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q791T5

Entry ID Method Resolution Chain Position Source
AF-Q791T5-F1 Predicted AlphaFoldDB

15 variants for Q791T5

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389416567 133 F>C No EVA
rs3389450149 151 G>V No EVA
rs3389447329 168 S>C No EVA
rs3389447283 219 S>L No EVA
rs3389452029 223 M>I No EVA
rs3411699757 236 V>M No EVA
rs3389416590 246 E>D No EVA
rs3389362132 249 L>E No EVA
rs3389428304 250 L>V No EVA
rs3389443775 333 D>E No EVA
rs3389452008 338 N>K No EVA
rs217585564 343 R>Q No EVA
rs13473933 355 S>Y No EVA
rs3389408096 362 Y>C No EVA
rs3389441191 381 S>T No EVA

No associated diseases with Q791T5

2 regional properties for Q791T5

Type Name Position InterPro Accession
repeat Mitochondrial substrate/solute carrier 81 - 176 IPR018108-1
repeat Mitochondrial substrate/solute carrier 192 - 280 IPR018108-2

Functions

Description
EC Number
Subcellular Localization
  • Mitochondrion outer membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
mitochondrial outer membrane The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

3 GO annotations of biological process

Name Definition
activation of cysteine-type endopeptidase activity involved in apoptotic process Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9NZJ7 MTCH1 Mitochondrial carrier homolog 1 Homo sapiens (Human) PR
10 20 30 40 50 60
MGASDPEVAP WAPGGAAGMA GAGAGAGARG GAPAGVEARA RDPPPAHRAH PRHPRPAAQP
70 80 90 100 110 120
SARRMDGGPG APGSGDNAPT TEALFVALGA GVTALSHPLL YVKLLIQVGH EPMPPTLGTN
130 140 150 160 170 180
VLGRKVLYLP SFFTYAKYIV QVDGKIGLFR GLSPRLMSNA LSTVTRGSMK KVFPPDEMEQ
190 200 210 220 230 240
VSNKDDMKTS LKKVVKETSY EMMMQCVSRM LAHPLHVISM RCMVQFVGRE AKYSGVLSSI
250 260 270 280 290 300
GKIFKEEGLL GFFVGLIPHL LGDVVFLWGC NLLAHFINAY LVDDSVSDTP GGLGNDQNPG
310 320 330 340 350 360
SQFSQALAIR SYTKFVMGIA VSMLTYPFLL VGDLMAVNNC GLRAGLPPYS PVFKSWIHCW
370 380
KYLSVQGQLF RGSSLLFRRV SSGSCFALE